The General Pharmaceutical Council is reminding pharmaceutical professionals and others of its consultation on strengthening its hearings and outcomes guidance for fitness to practise panels. The consultation ends on 31 January 2023.
About our proposals
The GPhC are proposing to strengthen its decision-making guidance for fitness to practise panels in two important areas:
- supporting decision-making in hearings where discrimination is a component
- taking account of cultural factors when panels are deciding on an outcome
The proposed update to the guidance makes clear what we mean by discrimination, bullying and harassment, and how seriously concerns of this nature will be taken.
The revised guidance will also make sure that panel members consider cultural sensitivities and differences when taking account of expressions of apology and insight. For example someone communicating in a second language may be constructing their sentences in a different way, or there may be differences in the way individuals use non-verbal cues such as eye contact or facial expressions.